Donate

March 1983

March 12, 2019

HHS begins approving licensing for heat-treatment of clotting factor. Several US manufacturers begin the development of heat-treated factor concentrate after testing shows the process kills both the HIV and hepatitis viruses.


Sign up for E-mails, Dateline Magazine, and other ways to stay connected.